Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-18-011003
Filing Date
2018-08-29
Accepted
2018-08-29 18:24:08
Documents
1
Period of Report
2018-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3525
  Complete submission text file 0001179110-18-011003.txt   4904
Mailing Address 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Shafer Bradford J (Reporting) CIK: 0001302448 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 181045188

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations